Monoglucosylated Oligomannosides Are Released during the Degradation Process of Newly Synthesized Glycoproteins*

René CacanDagger §, Sandrine DuvetDagger , Odette LabiauDagger , André VerbertDagger dagger, and Sharon S. Krag

From the Dagger  Laboratoire de Chimie Biologique, CNRS-UMR 8576, Université des Sciences et Technologies de Lille, 59655 Villeneuve d'Ascq Cedex, France and the  Department of Biochemistry, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Maryland 21205

Received for publication, February 5, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The Chinese hamster ovary mutant MI8-5 is known to synthesize Man9GlcNAc2-P-P-dolichol rather than the fully glucosylated lipid intermediate Glc3Man9GlcNAc2-P-P-dolichol. This nonglucosylated oligosaccharide lipid precursor is used as donor for N-glycosylation. In this paper we demonstrate that a significant part of the glycans bound to the newly synthesized glycoproteins in MI8-5 cells are monoglucosylated. The presence of monoglucosylated glycans on glycoproteins determines their binding to calnexin as part of the quality control machinery. Furthermore, we point out the presence of Glc1Man5GlcNAc1 in the cytosol of MI8-5 cells. This indicates that part of the monoglucosylated glycoproteins can be directed toward a deglycosylation process that occurs in the cytosol. Besides studies on glycoprotein degradation based on the disappearance of protein moieties, MI8-5 cells can be used as a tool to elucidate the various step leading to glycoprotein degradation by studying the fate of the glycan moieties.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

A key reaction of N-glycosylation is the transfer en bloc of a Glc3Man9GlcNAc2 oligosaccharide from a lipid intermediate to an Asn residue in the Asn-Xaa-Ser(Thr) consensus sequence of a nascent protein. This N-glycosylation process is immediately followed by sequential deglucosylation leading to Man9GlcNAc2 protein. It is now clearly established that oligosaccharide trimming in the ER1 is intimately linked to the quality control process, leading to the degradation of misfolded glycoproteins or unassembled multimeric proteins. Indeed the presence of monoglucosylated oligomannosides on glycoproteins retained in the ER is essential for their binding to the molecular chaperones calnexin and calreticulin (1, 2). The presence of a glucosyl residue is controlled by reglucosylation-deglucosylation cycles involving UDP-glucose : glycoprotein glucosyltransferase acting as a folding sensor (3) and glucosidase II, respectively. It has been demonstrated that glucose trimming and reglucosylation cycles determine the association of a glycoprotein with calnexin, as well as its folding (4, 5).

During this quality control, part of newly synthesized glycoproteins are degraded after translocation of the glycosylated polypeptide chains from the ER to the cytosol. As first demonstrated by Wiertz et al. (6), using labeled protein with an amino acid precursor, this retrotranslocation is accompanied by the removal of the glycans by a cytosolic peptide N-glycanase (PNGase), such as the one isolated by Suzuki et al. (7). The relationship between the location of the enzyme and the degradation process has been discussed by Karaivanova and Spiro (8). However, it is worth mentioning that few labs follow the fate of newly synthesized proteins by labeling with [2-3H]mannose. In this case, the N-glycosylation process is accompanied by the release of glycans from either lipid intermediates or from newly synthesized glycoproteins (9-11). The trafficking of the released oligomannosides from both origins leads to the formation of oligosaccharides possessing one GlcNAc residue at the reducing end (OSGn1) in the cytosol (for reviews see Refs. 12-14).

A Chinese hamster ovary mutant, MI8-5, was found to synthesize Man9GlcNAc2-P-P-Dol rather than fully glucosylated lipid intermediate (15). This mutant cell line was found to be deficient in dolichol-P-Glc:Man9GlcNAc2-P-P-dolichol glucosyl transferase activity. This defect is similar to the one observed for CDGIc (congenital disorders of glycosylation) (16).

In this paper, we demonstrate that although in MI8-5 the oligosaccharide lipids are nonglucosylated, part of the glycans bound to glycoproteins are monoglucosylated. Furthermore, we observe the formation of Glc1Man5GlcNAc1 species that could only originate from a deglycosylation mechanism occurring during glycoprotein degradation. Our work demonstrates that the quality control system for newly synthesized glycoproteins is intact in MI8-5 cells. This cell line gives us a biological model to determine the nature of oligosaccharides released from protein independently of what is happening at the reducing end.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Reagents-- Mutant cell line MI8-5 was isolated as described previously (15). [2-3H]Mannose (429 Gbq/mmol) and [U-14C]glucose (10 Gbq/mmol) were from Amersham Pharmacia Biotech. PNGase F and castanospermine were purchased from Glyko, (Novato, CA). alpha -Mannosidase from jack bean, protease inhibitors, and trypsin were obtained from Sigma. Polyclonal antibody anti-calnexin was from StressGen. Protein A-Sepharose CL-4B and concanavalin A-Sepharose were from Amersham Pharmacia Biotech.

Metabolic Labeling of Oligosaccharides and Chase Experiments-- MI8-5 cells were routinely cultured in monolayers in alpha -minimal essential medium with 10% (v/v) fetal calf serum at 34 °C in 10-cm Petri dishes under air/CO2 (19:1). Cells were labeled with 50 µCi/ml of [2-3H]mannose in alpha -minimal essential medium containing 0.5 mM glucose and 10% dialyzed fetal bovine serum. After incubation, the medium was removed, and the cell layer was rinsed rapidly twice with ice-cold PBS. When a chase was performed, pulse-labeled cells were washed twice with PBS and incubated for different times in alpha -minimal essential medium containing 5 mM glucose. When used, castanospermine (Cst) was maintained throughout the incubation and the chase periods at a final concentration of 50 µg/ml. Sequential extraction and purification of free oligosaccharide material were then achieved as described previously (9).

Analysis of Oligosaccharide Material-- The protein pellet was digested overnight at room temperature with 0.2 mg of trypsin in 0.1 M ammonium bicarbonate, pH 7.9. The glycan moiety linked to protein was cleaved by PNGase F as follows: the trypsin-treated protein was boiled for 10 min to destroy the trypsin activity, and the peptides were dried and dissolved in 20 mM sodium phosphate buffer, pH 7.5, containing 50 mM EDTA, 50% (v/v) glycerol, and 0.02% NaN3. PNGase F was then added (0.5 mIU) for incubation overnight at 37 °C.

Size analysis of the glycan moieties was achieved by HPLC on an amino-derivatized Asahipak NH2P-50 (250 mm × 4.6 mm) column (Asahi, Kawasaki-ku, Japan) with a solvent system of acetonitrile/water from 70:30 (v/v) to 50:50 (v/v) at a flow rate of 1 ml/min over 80 min. Under these conditions the oligomannosides can be resolved by their numbers of mannose, glucose, and GlcNAc residues from Man to Glc3Man9GlcNAc2. Oligomannosides were identified by their retention times as described previously (9); separation of the labeled oligosaccharides was monitored by continuous-flow detection of the radioactivity with a Flo-one beta  detector (Packard).

Jack Bean alpha -Mannosidase Treatment-- For enzymatic treatment with jack bean alpha -mannosidase, oligosaccharides released after PNGase digestion were dissolved in 20 µl of 50 mM sodium acetate buffer, pH 5. The incubation was achieved overnight at 37 °C with 0.5 units of jack bean alpha -mannosidase. The incubation mixture was then analyzed by HPLC.

[U-14C]Glucose Labeling for Glucosyl Residue Detection-- MI8-5 cells were labeled with 25 µCi/ml of [U-14C]glucose per dish in alpha -minimal essential medium without glucose containing 5 mM mannose, 50 µg/ml Cst, and 10% dialyzed fetal bovine serum. Pulse-labeled cells were washed twice with PBS and chased during 2 h in alpha -minimal essential medium containing 5 mM glucose and 50 µg/ml Cst. Sequential extraction was then achieved as described previously (9).

The protein pellet was digested overnight at room temperature with trypsin in 0.1 M ammonium bicarbonate, pH 7.9, and glycans were then removed by PNGase F treatment. Both oligosaccharides bound to glycoproteins, and free oligosaccharides were purified by concanavalin A chromatography. The lectin column (concanavalin A-Sepharose; 5 × 0.5 cm) was equilibrated in 5 mM sodium acetate buffer, pH 5.2, containing 0.1 M NaCl, 1 mM MnCl2, 1 mM CaCl2, and 1 mM MgCl2 at room temperature. The fraction resulting from PNGase F action on glycoprotein fraction and free oligosaccharides were applied to the column. The strongly retained [14C]-labeled oligomannosides were eluted with 100 mM alpha -D-mannoside. Peak A (originating from glycoproteins) and peak B (originating from free oligomannoside material) were then isolated by preparative HPLC. The isolated peaks A and B were then submitted to acid hydrolysis (4 M trifluoroacetic acid at 100 °C during 4 h). After drying under nitrogen, free monosaccharides were cochromatographed with [2-3H]mannose as an internal standard using HPLC under isocratic conditions with a solvent system of acetonitrile/water (80:20 (v/v)) at a flow rate of 1 ml/min over 20 min.

Cell Lysis and Immunoprecipitation by Anti-calnexin Antibody-- [2-3H]Mannose-labeled cells were washed twice with cold PBS and lysed in buffer (50 mM Hepes, pH 7.4, 200 mM NaCl, 2% CHAPS) containing a mixture of protease inhibitors (10 µg/ml pepstatin and leupeptin, 1 mg/ml 4-(2 aminoethyl) benzene-sulfonyl fluoride, and 0.1 mM diisopropylfluorophosphate). The cell lysate was centrifuged at 14000 × g for 3 min at 4 °C to remove insoluble material.

The cell lysate was precleared with protein A-Sepharose beads and immunoprecipitated for 16 h at 4 °C with anti-calnexin antibodies prebound to protein A-Sepharose beads. Immunoprecipitates were washed thrice in high salt buffer (50 mM Hepes, pH 7.4, 200 mM NaCl, 0.5% CHAPS) followed by two washes in 20 mM Hepes, pH 7.4. Immunoprecipitated [2-3H]mannose-labeled glycoproteins were digested overnight at room temperature with 0.2 mg of trypsin in 0.1 M ammonium bicarbonate, pH 7.9. After PNGase treatment, glycan moieties linked to protein were analyzed by HPLC as described above.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Pattern of Glycans Bound to Glycoproteins Synthesized by MI8-5 Cell Line-- MI8-5 cells transfer onto proteins only nonglucosylated oligosaccharides (15). To compare the fate of glycans bound to glycoproteins synthesized in parental (K1-2 cells) and MI8-5, these cells were pulse-labeled during 60 min with [2-3H]mannose in the conditions described under "Materials and Methods." Fig. 1, a and b represent the pattern of glycans released from glycoproteins of K1-2 and MI8-5 after PNGase treatment. Although the oligosaccharide bound to lipid intermediates in K1-2 and MI8-5 cells was different (Glc3Man9GlcNAc2-PP-Dol for parental cells and Man9GlcNAc2-PP-Dol for mutant cells), the oligomannoside species bound to proteins seems to be similar. In particular, a species having a higher retention time than Man9GlcNAc2 can be detected in MI8-5 (peak A). This raised the question of the nature and of the molecular composition of this oligomannosides species.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Analysis of oligosaccharide species bound to glycoproteins of parental (K1-2) and MI8-5 cell lines. Cells were pulse-labeled with [2-3H]mannose for 1 h. After sequential extraction, glycoproteins were treated with PNGase, and the released oligosaccharides were analyzed by HPLC as described under "Materials and Methods." a, glycans from K1-2 cells; b, glycans from MI8-5 cells. G1M9 indicates oligomannosides containing one glucose, nine mannose, and two N-acetyl glucosamine residues; M9 and M8 indicate oligomannosides containing nine or eight mannose and two N-acetyl glucosamine residues, respectively.

Peak A has been isolated, and its sensitivity toward jack bean alpha -mannosidase has been compared with the Man9GlcNAc2 species used as control. The action of jack bean alpha -mannosidase on isolated Man9GlcNAc2 species (Fig. 2a) leads to the formation of 88% of free mannose and 12% of Man1GlcNAc2 species (see Fig. 2b and Table I). These results indicate that the totality of alpha -linked mannose residues has been removed. In contrast, the same incubation of isolated peak A (Fig. 2c) with jack bean alpha -mannosidase leads to the formation of 30% of free mannose and 70% of higher species migrating as hexose(6-8)GlcNAc2, peaks 1, 2, and 3, respectively (see Fig. 2d and Table I). The absence of a resulting Man1GlcNAc2 species suggests that only partial hydrolysis of peak A was performed by the enzyme. It has to be noted that when incubation was achieved with higher enzyme concentration, the proportion of peak 1 increases, but peaks 2 and 3 remained detectable. This suggests that peak 1 is the limit product of the hydrolysis of peak A by jack bean alpha -mannosidase. Moreover, peak 1 comigrated with the Glc1Man5GlcNAc2 species that corresponds to the major oligomannoside species synthesized by mannosylphosphoryldolichol-deficient cell line B3F7 (not shown). Partial digestion of Glc3Man9GlcNAc2 species isolated from the glucosidase I-deficient cell line Lec23 has also been obtained leading to a mixture of three species (17). As in our case, complete digestion to a single product was not observed even after longer incubations. Furthermore, it has been clearly demonstrated on bovine rhodopsin that jack bean alpha -mannosidase is not able to cleave an unsubstituted alpha 1,6-linked mannose from the core beta -mannose (18). Our results are consistent with these observations, because the smallest species is Glc1Man5GlcNAc2. According to our results, we can postulate that peaks 1, 2, and 3 correspond to Glc1Man5GlcNAc2, Glc1Man6GlcNAc2, and Glc1Man7GlcNAc2, respectively.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 2.   Jack bean alpha -mannosidase digestion of oligosaccharide species bound to glycoproteins isolated from MI8-5 cells. MI8-5 cells were pulse-labeled with [2-3H]mannose for 1 h. After sequential extraction, glycoproteins were treated with PNGase, and Man9GlcNAc2 (panel a) and peak A (panel c) were isolated by HPLC. 50,000 dpm of each peak was treated overnight by jack bean alpha -mannosidase as described under "Materials and Methods." Hydrolysates were then analyzed by HPLC. Panel b, analysis of Man9GlcNAc2 hydrolysis product; panel d, analysis of peak A hydrolysis product. M9 and M1 indicate oligomannosides containing nine or one mannose and two N-acetyl glucosamine residues, respectively. Man indicates free mannose.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Proportion of various species obtained after jack bean alpha -mannosidase treatment of [2-3H]mannose-labeled oligomannoside species isolated from MI8-5 glycoproteins
The values are expressed as percent of the input radioactivity.

Effect of Castanospermine on the Pattern of Glycans Bound onto Glycoproteins in MI8-5 Cells-- MI8-5 cells were metabolically labeled with tritiated mannose in the presence of 50 µg/ml of Cst (an inhibitor of rough ER glucosidases). Comparing panels a and b of Fig. 3, there was clearly an increase of the radioactivity bound to peak A in the presence of Cst. As Cst has been demonstrated to prevent deglucosylation of newly synthesized glycoproteins, this observation strongly suggests that peak A represents a glucosylated species.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of castanospermine on the pattern of glycans bound to glycoproteins and free oligomannosides synthesized by MI8-5 cells. MI8-5 cells were pulse labeled with [2-3H]mannose for 1 h in the absence (panels a and c) or in the presence (panels b and d) of 50 µg/ml Cst. After sequential extraction, the free oligosaccharide material (panels c and d) and the glycans released from glycoproteins with PNGase (panels a and b) were analyzed by HPLC as described under "Materials and Methods." M9, M8, M5, M4, and M3 indicate oligomannosides containing nine, eight, five, four, and three mannose residues, respectively. Open peaks represent oligomannosides possessing two N-acetyl glucosamine residues at the reducing end, and hatched peaks represent oligomannosides possessing one N-acetyl glucosamine residue at the reducing end.

Occurrence of a Glucose Residue on Glycoproteins Synthesized by MI8-5 Cells-- MI8-5 cells were pulse-labeled with [U-14C]glucose during 1 h in the presence of 50 µg/ml of Cst as described under "Materials and Methods." After a PNGase treatment of the protein pellet, oligomannoside-type glycans were purified by concanavalin A chromatography. [14C]-Labeled peak A (see Fig. 1b) was then isolated by HPLC and submitted to acid hydrolysis to release monosaccharides. Fig. 4b shows chromatography of the [14C]-labeled hydrolysate of peak A with [2-3H]mannose as an internal standard. The HPLC profile showed the presence of both [14C]mannose and glucose residues. All the data from HPLC, alpha -mannosidase treatment, and composition analysis demonstrate that the species migrating as peak A is glucosylated and possesses the following molar composition: Glc1Man9GlcNAc2.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   Glycoproteins and free oligomannosides synthesized by MI8-5 cells are glucosylated. MI8-5 cells were pulse-labeled with [U-14C]glucose for 1 h and then the radioactivity was chased for 2 h in the presence of 50 µg/ml Cst. After sequential extraction, the glycans released from glycoproteins with PNGase and the free oligomannosides were purified by concanavalin A chromatography. Peaks A and B (see Figs. 1 and 3) were then isolated from glycoproteins and free oligomannosides, respectively, and submitted to acid hydrolysis as described under "Materials and Methods." The [14C]-labeled monosaccharides are then cochromatographed with [2-3H]mannose using HPLC under isocratic conditions. Panel a indicates the separation of free mannose and glucose; panel b shows the analysis of monosaccharides obtained after the hydrolysis of oligosaccharide A isolated from glycoproteins; panel c shows the analysis of monosaccharides obtained after the hydrolysis of oligosaccharide B isolated from free oligomannosides.

Glucosylation of Newly Synthesized Glycoproteins in MI8-5 Allows Binding to Calnexin-- Because oligomannosides synthesized in MI8-5 are transferred onto nascent proteins as nonglucosylated species, it can be assumed that the presence of Glc1Man9GlcNAc2 bound to glycoproteins originated from a subsequent glucosylation process of the Man9GlcNAc2 species. At the present time it has been well demonstrated that the presence of the glucosyl residue is controlled by reglucosylation-deglucosylation cycles involving the UDP-glucose : glycoprotein glucosyltransferase and glucosidase II, respectively (3). Recently it has been demonstrated that the trimming and readdition of glucose to N-linked oligosaccharides determine the association of a glycoprotein with calnexin, as well as its folding (4, 5). We next determined whether the reglucosylation of oligomannosides onto glycoproteins seen in MI8-5 cells resulted in an association with calnexin. MI8-5 cells were pulse-labeled for 1 h with [2-3H]mannose, and the radioactivity was chased for 1 h. To preserve glucosylated oligomannosides, Cst was maintained in the media during the entire experiment. After immunoprecipitation of the cell lysate with anti-calnexin antibodies, immunoprecipitated glycoproteins were trypsin-treated and subjected to a PNGase treatment before being analyzed by HPLC. Fig. 5 reveals the presence of two peaks, the first one migrating as Glc1Man9GlcNAc2 and the second one as Glc1Man8GlcNAc2. The hydrolysis of each peak by jack bean alpha -mannosidase leads to the same pattern as the one obtained after hydrolysis of Glc1Man9GlcNAc2 (peak A) isolated from glycoproteins (Table I). These results indicate that the reglucosylated oligomannoside glycans of MI8-5 could associate with calnexin. Therefore, the quality control system for newly synthesized glycoproteins appeared intact in MI8-5 cells.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Oligomannosides species bound to glycoproteins associated with calnexin in MI8-5 cells. MI8-5 cells were pulse-labeled with [2-3H]mannose for 1 h and then the radioactivity was chased for 1 h in the presence of 50 µg/ml Cst. Immunoprecipitation of the cell lysate with anti-calnexin antibody was performed as described under "Materials and Methods." The immunoprecipitates were then treated by PNGase, and the oligosaccharide material was analyzed by HPLC after purification. G1M9 and G1M8 indicate oligomannosides containing one glucose, nine or eight mannose, and two N-acetyl glucosamine residues.

Monoglucosylated Free Oligomannosides Are Produced by MI-5 Cells-- It has been shown that the N-glycosylation process is accompanied by the release of free oligomannoside material originating from both oligosaccharide-lipid hydrolysis and degradation of glycoproteins (12-14). It has also been demonstrated in mutant cell lines lacking mannosylphosphoryldolichol that the free oligosaccharides released from oligosaccharide-lipid or glycoprotein are degraded into an oligomannoside isomer, Man5GlcNAc1 (9). Because MI8-5 cells do not glucosylate the glycan bound to oligosaccharide-PP-Dol but do glucosylate the glycans on proteins, this offers a biological model to discriminate oligosaccharides originating from glycoproteins. Indeed, after plasma membrane permeabilization with streptolysine O of MI8-5 cells (not shown), free oligomannosides are released from semi-intact cells indicating their cytosolic location. As shown in Fig. 3c these oligomannosides recovered after a pulse-chase experiment with [2-3H]mannose possessed one GlcNAc residue at the reducing end indicating that they have been processed in the cytosol. Man5GlcNAc1 appeared as the major species. However, a peak B having a higher retention time could be observed. The proportion of radioactivity associated with peak B increased from 20 to 80% in the presence of 50 µg/ml Cst (Fig. 3d). Peak B was isolated after a pulse labeling of MI8-5 cells for 1 h in the presence of [U-14C]glucose and 50 µg/ml Cst. As shown in Fig. 6, the cochromatography of this peak B with free oligomannosides synthesized by B3F7 cells (a Man-P-Dol-deficient cell line that synthesizes only truncated Man5 bearing oligomannosides) reveals that peak B coeluted with Glc1Man5GlcNAc1 species. Acid hydrolysis of the [14C]-labeled peak B revealed the presence of both mannose and glucose residues (Fig. 4c). These data indicate that in MI8-5 cells, glucosylated glycans bound to glycoproteins are released and processed to give a unique intermediate, Glc1Man5GlcNAc1.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 6.   Cochromatography of free oligomannosides synthesized by the Man-P-Dol-deficient cell line B3F7 and peak B isolated from free oligomannosides synthesized by MI8-5 cells. MI8-5 cells were pulse-labeled with [U-14C]glucose for 1 h and then the radioactivity was chased for 2 h in the presence of 50 µg/ml Cst. After sequential extraction, the free oligomannosides were purified by concanavalin A chromatography. Peak B was then isolated and cochromatographed together with free oligomannosides purified from B3F7 cells pulse-labeled with [2-3H]mannose. G1M5 indicates oligomannoside possessing one glucose residue and five mannose residues, and M5, M4, and M3 indicate oligomannosides containing five, four, and three mannose residues, respectively. Hatched peaks represent oligomannosides possessing one N-acetyl glucosamine residue at the reducing end.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The lack of dolichol-P-Glc:Man9GlcNAc2-P-P-dolichol glucosyl transferase activity in MI8-5 cells leads to the synthesis of nonglucosylated Man9GlcNAc2-P-P-dolichol, which is transferred to protein (15). In this paper, we show that reglucosylation-deglucosylation cycles occur on glycoproteins of MI8-5 cells, because the presence of monoglucosylated glycans has been demonstrated. As in all cell lines studied up to now, the presence of monoglucosylated glycans determines the association of newly synthesized glycoproteins with calnexin. Indeed, immunoprecipitation of glycoproteins synthesized in MI8-5 cells by anti-calnexin antibodies revealed the presence of two oligomannoside species, Glc1Man8GlcNAc2 and Glc1Man9GlcNAc2.

The more interesting aspect of this work is the demonstration that the Glc1Man5GlcNAc1 species is a component of the soluble free oligomannoside material. These glucosylated oligosaccharides originated from glycoproteins, because in MI8-5 cells glucosyl residues are recovered only on glycoproteins. Endoplasmic reticulum to cytosol transport of oligomannosides possessing two GlcNAc residues at the reducing end (OSGn2) is known to be specific for nonglucosylated species (19, 20). Moreover, it is now well established that OSGn2 are converted to OSGn1 species by a cytosolic chitobiase (21). Thus the finding of glucosylated OSGn1 in MI8-5 cells indicates that the deglycosylation process of glycoproteins occurred in the cytosol prior to their degradation.

When looking at the reducing end of the released oligomannosides, a discrepancy appears between the previous demonstration of the PNGase action (6) releasing OSGn2 and the monoglucosylated OSGn1 observed in this study. Two alternatives can be proposed, either there was successive action of PNGase and chitobiase, or there was cleavage by a cytosolic beta -endoglucosaminidase (22, 23).

The study of oligomannosides produced by MI8-5 cells suggests the following pathway for the formation of Glc1Man5GlcNAc1: after retrotranslocation of polypeptides bearing monoglucosylated glycans (Glc1Man8GlcNAc2 and Glc1Man9GlcNAc2), deglycosylation occurs in cytosol liberating Glc1Man8GlcNAc1 and Glc1Man9GlcNAc1. These OSGn1 are substrates for the cytosolic alpha -mannosidase (24) generating the observed Glc1Man5GlcNAc1. The fate of this oligosaccharide is still in question, because up to now, no alpha -glucosidase activity has been detected in the cytosol. Although its transport into lysosomes has not yet been studied (25), our results suggest a lysosomal degradation into Man5GlcNAc1 and lower species. The question remains whether glycoproteins bearing monoglucosylated glycans and being directed toward degradation must be linked to calnexin, as demonstrated by Liu et al. (26) for the degradation of misfolded alpha 1-antitrypsin.

    FOOTNOTES

* This work was supported in part by European Economic Communautee Contract ERB FMRX CT96 0025 (Carenet-2) from CNRS and Université des Sciences et Technologies de Lille, Grant 9736 from the Association pour la Recherche sur le Cancer, and National Institutes of Health Grant R01 CA 20421 (to S. S. K.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

We dedicate this article to the memory of our coauthor, André Verbert. We will miss his friendship and enthusiasm for science.

dagger Deceased May 20, 2000.

§ To whom correspondence should be addressed. Tel.: 33-3-20-43-44-30; Fax: 33-3-20-43-65-55; E-mail: Rene.Cacan@univ-lille1.fr.

Published, JBC Papers in Press, April 6, 2001, DOI 10.1074/jbc.M101077200

    ABBREVIATIONS

The abbreviations used are: ER, endoplasmic reticulum; PNGase, peptide N-glycanase; OSGn1, one GlcNAc residue at the reducing end. Dol, dolichol; PBS, phosphate-buffered saline; Cst, castanospermine; HPLC, high pressure liquid chromatography; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio[-1-propanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Ware, F. E., Vassilakos, A., Peterson, P. A., Jackson, M. R., Lehrman, M. A., and Williams, D. B. (1995) J. Biol. Chem. 270, 4697-4704[Abstract/Free Full Text]
2. Spiro, R. G., Zhu, Q., Bhoyroo, V., and Söling, H. D. (1996) J. Biol. Chem. 271, 11588-11594[Abstract/Free Full Text]
3. Sousa, M. C., and Parodi, A. J. (1995) EMBO J. 14, 4196-4203[Abstract]
4. Hebert, D. N., Foellmer, B., and Helenius, A. (1995) Cell 81, 425-433[Medline] [Order article via Infotrieve]
5. Cannon, K. S., and Helenius, A. (1999) J. Biol. Chem. 274, 7537-7544[Abstract/Free Full Text]
6. Wiertz, E. J. H. J., Jones, T. R., Sun, L., Bogyo, M., Geuze, H. J., and Ploegh, H. L. (1996) Cell 84, 769-779[Medline] [Order article via Infotrieve]
7. Suzuki, T., Seko, A., Kitajima, K., Inoue, Y., and Inoue, S. (1994) J. Biol. Chem. 269, 17611-17618[Abstract/Free Full Text]
8. Karaivanova, V. K., and Spiro, R. G. (2000) Glycobiology 10, 727-735[Abstract/Free Full Text]
9. Kmiécik, D., Herman, V., Stroop, C. J. M., Michalski, J. C., Mir, A. M., Labiau, O., Verbert, A., and Cacan, R. (1995) Glycobiology 5, 483-494[Abstract]
10. Anumula, R. K., and Spiro, R. G. (1983) J. Biol. Chem. 258, 15274-15282[Abstract/Free Full Text]
11. Saint-Pol, A., Bauvy, C., Codogno, P., and Moore, S. E. H. (1997) J. Cell Biol. 136, 45-59[Abstract/Free Full Text]
12. Cacan, R., and Verbert, A. (1999) Biochem. Biophys. Res. Com. 258, 1-5[CrossRef][Medline] [Order article via Infotrieve]
13. Verbert, A., and Cacan, R. (1999) Biochim. Biophys. Acta 1473, 137-146[Medline] [Order article via Infotrieve]
14. Moore, S. E. H. (1999) Trends Cell Biol. 9, 441-446[CrossRef][Medline] [Order article via Infotrieve]
15. Quellhorst, G. J., O'Rear, J. L., Cacan, R., Verbert, A., and Krag, S. S. (1999) Glycobiology 9, 65-72[Abstract/Free Full Text]
16. Burda, P., Borsig, L., de Rijk-van Andel, J., Wevers, R., Jaeken, J., Carchon, H., Berger, E. G., and Aebi, M. (1998) J. Clin. Invest. 102, 647-652[Abstract/Free Full Text]
17. Ray, M. K., Yang, J., Sundaram, S., and Stanley, P. (1991) J. Biol. Chem. 266, 22818-22825[Abstract/Free Full Text]
18. Liang, C. J., Yamashita, K., Muellenberg, C. G., Shichi, H., and Kobata, A. (1979) J. Biol. Chem. 254, 6414-6418[Abstract]
19. Moore, S. E. H., Bauvy, C., and Codogno, P. (1995) EMBO J. 14, 6034-6042[Abstract]
20. Duvet, S., Labiau, O., Mir, A. M., Kmiécik, D., Krag, S. S., Verbert, A., and Cacan, R. (1998) Biochem. J. 335, 389-396[Medline] [Order article via Infotrieve]
21. Cacan, R., Dengremont, C., Labiau, O., Kmiécik, D., Mir, A. M., and Verbert, A. (1996) Biochem. J. 313, 597-602[Medline] [Order article via Infotrieve]
22. Pierce, R. J., Spik, G., and Montreuil, J. (1979) Biochem. J. 180, 673-676[Medline] [Order article via Infotrieve]
23. Pierce, R. J., Spik, G., and Montreuil, J. (1980) Biochem. J. 185, 261-264[Medline] [Order article via Infotrieve]
24. Grard, T., Herman, V., Saint-Pol, A., Kmiécik, D., Labiau, O., Mir, A. M., Alonso, C., Verbert, A., Cacan, R., and Michalski, J. C. (1996) Biochem. J. 316, 787-792[Medline] [Order article via Infotrieve]
25. Saint-Pol, A., Codogno, P., and Moore, S. E. H. (1999) J. Biol. Chem. 274, 13547-13555[Abstract/Free Full Text]
26. Liu, Y., Choudhury, P., Cabral, C. M., and Sifers, R. N. (1999) J. Biol. Chem. 274, 5861-5867[Abstract/Free Full Text]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.